APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics Platforms

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Digital Therapeutics Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 March 2026194 pages

Choose your research edition.

Industry ResearchDigital Therapeutics Platforms Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics Platforms Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics Platforms Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics Platforms Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Digital Therapeutics Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Digital Therapeutics Platforms include Akili Interactive, DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Talkspace, CogniFit and Tata Elxsi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Digital Therapeutics Platforms market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Therapeutics Platforms and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Therapeutics Platforms revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Digital Therapeutics Platforms market size, projected growth trends, production technologies, key applications, and end-use industries.

Digital Therapeutics Platforms Segment by Company

Akili Interactive

DarioHealth

Teladoc Health

Voluntis

Sidekick Health

WellDoc

Talkspace

CogniFit

Tata Elxsi

Mahalo Health

2Morrow

Omada Health

Click Therapeutics

Orexo

ResMed

Virta Health

Bifourmis

SilverCloud (Amwell)

Noom

Big Health

Kaia Health

Cognoa

Headspace Health

CureApp

Calm Health

Riva Health

Sweetch-Health

Lark Health

Vida Health

Mahana Therapeutics

Blue Note Therapeutics

Lyra Health

Modern Health

Canary Health

Virgin Pulse

Slanhealth

Best Covered

Dami and Xiaomi

WeiMai

Jianhai Tech

Digital Therapeutics Platforms Segment by Type

Chronic Disease Digital Therapeutics

Psychiatric Disorders Digital Therapeutics

Quit Smoking Digital Therapeutics

Sleep Disorders and Respiratory Diseases Digital Therapeutics

Others

Digital Therapeutics Platforms Segment by Application

Enterprise

Personal

Digital Therapeutics Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Digital Therapeutics Platforms in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Therapeutics Platforms industry.

Chapter 3: Detailed analysis of Digital Therapeutics Platforms companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Therapeutics Platformsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Therapeutics Platforms Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chronic Disease Digital Therapeutics Table 3. Key Players of Psychiatric Disorders Digital Therapeutics Table 4. Key Players of Quit Smoking Digital Therapeutics Table 3. Key Players of Sleep Disorders and Respiratory Diseases Digital Therapeutics Table 4. Key Players of Others Table 5. Global Digital Therapeutics Platforms Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Enterprise Table 7. Key Players of Personal Table 8. Global Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Digital Therapeutics Platforms Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Digital Therapeutics Platforms Market Share by Region (2021-2026) Table 11. Global Digital Therapeutics Platforms Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Digital Therapeutics Platforms Market Share by Region (2027-2032) Table 13. Digital Therapeutics Platforms Industry Trends Table 14. Digital Therapeutics Platforms Industry Drivers Table 15. Digital Therapeutics Platforms Industry Opportunities and Challenges Table 16. Digital Therapeutics Platforms Industry Restraints Table 17. Global Digital Therapeutics Platforms Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Digital Therapeutics Platforms Revenue Market Share by Company (2021-2026) Table 19. Global Digital Therapeutics Platforms Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Digital Therapeutics Platforms Key Company Head Office and Area Served Table 21. Global Digital Therapeutics Platforms Company, Product Type & Application Table 22. Global Digital Therapeutics Platforms Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Digital Therapeutics Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Digital Therapeutics Platforms Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Digital Therapeutics Platforms Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Digital Therapeutics Platforms Revenue Market Share by Type (2021-2026) Table 29. Global Digital Therapeutics Platforms Revenue Market Share by Type (2027-2032) Table 30. Global Digital Therapeutics Platforms Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Digital Therapeutics Platforms Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Digital Therapeutics Platforms Revenue Market Share by Application (2021-2026) Table 34. Global Digital Therapeutics Platforms Revenue Market Share by Application (2027-2032) Table 35. Akili Interactive Company Information Table 36. Akili Interactive Business Overview Table 37. Akili Interactive Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Akili Interactive Digital Therapeutics Platforms Product Portfolio Table 39. Akili Interactive Recent Development Table 40. DarioHealth Company Information Table 41. DarioHealth Business Overview Table 42. DarioHealth Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. DarioHealth Digital Therapeutics Platforms Product Portfolio Table 44. DarioHealth Recent Development Table 45. Teladoc Health Company Information Table 46. Teladoc Health Business Overview Table 47. Teladoc Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Teladoc Health Digital Therapeutics Platforms Product Portfolio Table 49. Teladoc Health Recent Development Table 50. Voluntis Company Information Table 51. Voluntis Business Overview Table 52. Voluntis Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Voluntis Digital Therapeutics Platforms Product Portfolio Table 54. Voluntis Recent Development Table 55. Sidekick Health Company Information Table 56. Sidekick Health Business Overview Table 57. Sidekick Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sidekick Health Digital Therapeutics Platforms Product Portfolio Table 59. Sidekick Health Recent Development Table 60. WellDoc Company Information Table 61. WellDoc Business Overview Table 62. WellDoc Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. WellDoc Digital Therapeutics Platforms Product Portfolio Table 64. WellDoc Recent Development Table 65. Talkspace Company Information Table 66. Talkspace Business Overview Table 67. Talkspace Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Talkspace Digital Therapeutics Platforms Product Portfolio Table 69. Talkspace Recent Development Table 70. CogniFit Company Information Table 71. CogniFit Business Overview Table 72. CogniFit Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. CogniFit Digital Therapeutics Platforms Product Portfolio Table 74. CogniFit Recent Development Table 75. Tata Elxsi Company Information Table 76. Tata Elxsi Business Overview Table 77. Tata Elxsi Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Tata Elxsi Digital Therapeutics Platforms Product Portfolio Table 79. Tata Elxsi Recent Development Table 80. Mahalo Health Company Information Table 81. Mahalo Health Business Overview Table 82. Mahalo Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Mahalo Health Digital Therapeutics Platforms Product Portfolio Table 84. Mahalo Health Recent Development Table 85. 2Morrow Company Information Table 86. 2Morrow Business Overview Table 87. 2Morrow Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. 2Morrow Digital Therapeutics Platforms Product Portfolio Table 89. 2Morrow Recent Development Table 90. Omada Health Company Information Table 91. Omada Health Business Overview Table 92. Omada Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Omada Health Digital Therapeutics Platforms Product Portfolio Table 94. Omada Health Recent Development Table 95. Click Therapeutics Company Information Table 96. Click Therapeutics Business Overview Table 97. Click Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Click Therapeutics Digital Therapeutics Platforms Product Portfolio Table 99. Click Therapeutics Recent Development Table 100. Orexo Company Information Table 101. Orexo Business Overview Table 102. Orexo Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Orexo Digital Therapeutics Platforms Product Portfolio Table 104. Orexo Recent Development Table 105. ResMed Company Information Table 106. ResMed Business Overview Table 107. ResMed Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. ResMed Digital Therapeutics Platforms Product Portfolio Table 109. ResMed Recent Development Table 110. Virta Health Company Information Table 111. Virta Health Business Overview Table 112. Virta Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Virta Health Digital Therapeutics Platforms Product Portfolio Table 114. Virta Health Recent Development Table 115. Bifourmis Company Information Table 116. Bifourmis Business Overview Table 117. Bifourmis Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Bifourmis Digital Therapeutics Platforms Product Portfolio Table 119. Bifourmis Recent Development Table 120. SilverCloud (Amwell) Company Information Table 121. SilverCloud (Amwell) Business Overview Table 122. SilverCloud (Amwell) Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio Table 124. SilverCloud (Amwell) Recent Development Table 125. Noom Company Information Table 126. Noom Business Overview Table 127. Noom Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Noom Digital Therapeutics Platforms Product Portfolio Table 129. Noom Recent Development Table 130. Big Health Company Information Table 131. Big Health Business Overview Table 132. Big Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Big Health Digital Therapeutics Platforms Product Portfolio Table 134. Big Health Recent Development Table 135. Kaia Health Company Information Table 136. Kaia Health Business Overview Table 137. Kaia Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Kaia Health Digital Therapeutics Platforms Product Portfolio Table 139. Kaia Health Recent Development Table 140. Cognoa Company Information Table 141. Cognoa Business Overview Table 142. Cognoa Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Cognoa Digital Therapeutics Platforms Product Portfolio Table 144. Cognoa Recent Development Table 145. Headspace Health Company Information Table 146. Headspace Health Business Overview Table 147. Headspace Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. Headspace Health Digital Therapeutics Platforms Product Portfolio Table 149. Headspace Health Recent Development Table 150. CureApp Company Information Table 151. CureApp Business Overview Table 152. CureApp Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. CureApp Digital Therapeutics Platforms Product Portfolio Table 154. CureApp Recent Development Table 155. Calm Health Company Information Table 156. Calm Health Business Overview Table 157. Calm Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 158. Calm Health Digital Therapeutics Platforms Product Portfolio Table 159. Calm Health Recent Development Table 160. Riva Health Company Information Table 161. Riva Health Business Overview Table 162. Riva Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 163. Riva Health Digital Therapeutics Platforms Product Portfolio Table 164. Riva Health Recent Development Table 165. Sweetch-Health Company Information Table 166. Sweetch-Health Business Overview Table 167. Sweetch-Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 168. Sweetch-Health Digital Therapeutics Platforms Product Portfolio Table 169. Sweetch-Health Recent Development Table 170. Lark Health Company Information Table 171. Lark Health Business Overview Table 172. Lark Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 173. Lark Health Digital Therapeutics Platforms Product Portfolio Table 174. Lark Health Recent Development Table 175. Vida Health Company Information Table 176. Vida Health Business Overview Table 177. Vida Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 178. Vida Health Digital Therapeutics Platforms Product Portfolio Table 179. Vida Health Recent Development Table 180. Mahana Therapeutics Company Information Table 181. Mahana Therapeutics Business Overview Table 182. Mahana Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 183. Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio Table 184. Mahana Therapeutics Recent Development Table 185. Blue Note Therapeutics Company Information Table 186. Blue Note Therapeutics Business Overview Table 187. Blue Note Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 188. Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio Table 189. Blue Note Therapeutics Recent Development Table 190. Lyra Health Company Information Table 191. Lyra Health Business Overview Table 192. Lyra Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 193. Lyra Health Digital Therapeutics Platforms Product Portfolio Table 194. Lyra Health Recent Development Table 195. Modern Health Company Information Table 196. Modern Health Business Overview Table 197. Modern Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 198. Modern Health Digital Therapeutics Platforms Product Portfolio Table 199. Modern Health Recent Development Table 200. Canary Health Company Information Table 201. Canary Health Business Overview Table 202. Canary Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 203. Canary Health Digital Therapeutics Platforms Product Portfolio Table 204. Canary Health Recent Development Table 205. Virgin Pulse Company Information Table 206. Virgin Pulse Business Overview Table 207. Virgin Pulse Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 208. Virgin Pulse Digital Therapeutics Platforms Product Portfolio Table 209. Virgin Pulse Recent Development Table 210. Slanhealth Company Information Table 211. Slanhealth Business Overview Table 212. Slanhealth Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 213. Slanhealth Digital Therapeutics Platforms Product Portfolio Table 214. Slanhealth Recent Development Table 215. Best Covered Company Information Table 216. Best Covered Business Overview Table 217. Best Covered Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 218. Best Covered Digital Therapeutics Platforms Product Portfolio Table 219. Best Covered Recent Development Table 220. Dami and Xiaomi Company Information Table 221. Dami and Xiaomi Business Overview Table 222. Dami and Xiaomi Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 223. Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio Table 224. Dami and Xiaomi Recent Development Table 225. WeiMai Company Information Table 226. WeiMai Business Overview Table 227. WeiMai Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 228. WeiMai Digital Therapeutics Platforms Product Portfolio Table 229. WeiMai Recent Development Table 230. Jianhai Tech Company Information Table 231. Jianhai Tech Business Overview Table 232. Jianhai Tech Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 233. Jianhai Tech Digital Therapeutics Platforms Product Portfolio Table 234. Jianhai Tech Recent Development Table 235. North America Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 236. North America Digital Therapeutics Platforms Market Size by Type (2027-2032) & (US$ Million) Table 237. North America Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 238. North America Digital Therapeutics Platforms Market Size by Application (2027-2032) & (US$ Million) Table 239. North America Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. North America Digital Therapeutics Platforms Market Size by Country (2021-2026) Table 241. North America Digital Therapeutics Platforms Market Size by Country (2027-2032) Table 242. Europe Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 243. Europe Digital Therapeutics Platforms Market Size by Type (2027-2032) & (US$ Million) Table 244. Europe Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 245. Europe Digital Therapeutics Platforms Market Size by Application (2027-2032) & (US$ Million) Table 246. Europe Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. Europe Digital Therapeutics Platforms Market Size by Country (2021-2026) Table 248. Europe Digital Therapeutics Platforms Market Size by Country (2027-2032) Table 249. China Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 250. China Digital Therapeutics Platforms Market Size by Type (2027-2032) & (US$ Million) Table 251. China Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 252. China Digital Therapeutics Platforms Market Size by Application (2027-2032) & (US$ Million) Table 253. Asia Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 254. Asia Digital Therapeutics Platforms Market Size by Type (2027-2032) & (US$ Million) Table 255. Asia Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 256. Asia Digital Therapeutics Platforms Market Size by Application (2027-2032) & (US$ Million) Table 257. Asia Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 258. Asia Digital Therapeutics Platforms Market Size by Country (2021-2026) Table 259. Asia Digital Therapeutics Platforms Market Size by Country (2027-2032) Table 260. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 261. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Type (2027-2032) & (US$ Million) Table 262. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 263. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Application (2027-2032) & (US$ Million) Table 264. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 265. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021-2026) Table 266. South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2027-2032) Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Digital Therapeutics Platforms Product Image Figure 2. Global Digital Therapeutics Platforms Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Digital Therapeutics Platforms Market Share by Type: 2025 VS 2032 Figure 4. Chronic Disease Digital Therapeutics Image Figure 5. Psychiatric Disorders Digital Therapeutics Image Figure 6. Quit Smoking Digital Therapeutics Image Figure 7. Sleep Disorders and Respiratory Diseases Digital Therapeutics Image Figure 8. Others Image Figure 9. Global Digital Therapeutics Platforms Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Digital Therapeutics Platforms Market Share by Application: 2025 VS 2032 Figure 11. Enterprise Image Figure 12. Personal Image Figure 13. Global Digital Therapeutics Platforms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 15. Global Digital Therapeutics Platforms Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Digital Therapeutics Platforms Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Digital Therapeutics Platforms Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Digital Therapeutics Platforms Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digital Therapeutics Platforms Revenue Market Share by Type (2021-2032) Figure 22. Global Digital Therapeutics Platforms Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Digital Therapeutics Platforms Revenue Market Share by Application (2021-2032) Figure 24. North America Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 25. North America Digital Therapeutics Platforms Market Share by Type (2021-2032) Figure 26. North America Digital Therapeutics Platforms Market Share by Application (2021-2032) Figure 27. North America Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 28. United States Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 29. Canada Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 31. Europe Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 32. Europe Digital Therapeutics Platforms Market Share by Type (2021-2032) Figure 33. Europe Digital Therapeutics Platforms Market Share by Application (2021-2032) Figure 34. Europe Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 35. Germany Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 36. France Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 38. Italy Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 39. Russia Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 41. China Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 42. China Digital Therapeutics Platforms Market Share by Type (2021-2032) Figure 43. China Digital Therapeutics Platforms Market Share by Application (2021-2032) Figure 44. Asia Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 45. Asia Digital Therapeutics Platforms Market Share by Type (2021-2032) Figure 46. Asia Digital Therapeutics Platforms Market Share by Application (2021-2032) Figure 47. Asia Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 48. Japan Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 52. India Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 53. Australia Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Digital Therapeutics Platforms Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Digital Therapeutics Platforms Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 58. Brazil Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 63. UAE Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 65. Chile Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Chronic Disease Digital Therapeutics
  • Psychiatric Disorders Digital Therapeutics
  • Quit Smoking Digital Therapeutics
  • Sleep Disorders and Respiratory Diseases Digital Therapeutics
  • Others
Applications
  • Enterprise
  • Personal
Companies covered
  • Akili Interactive
  • DarioHealth
  • Teladoc Health
  • Voluntis
  • Sidekick Health
  • WellDoc
  • Talkspace
  • CogniFit
  • Tata Elxsi
  • Mahalo Health
  • 2Morrow
  • Omada Health
  • Click Therapeutics
  • Orexo
  • ResMed
  • Virta Health
  • Bifourmis
  • SilverCloud (Amwell)
  • Noom
  • Big Health
  • Kaia Health
  • Cognoa
  • Headspace Health
  • CureApp
  • Calm Health
  • Riva Health
  • Sweetch-Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Blue Note Therapeutics
  • Lyra Health
  • Modern Health
  • Canary Health
  • Virgin Pulse
  • Slanhealth
  • Best Covered
  • Dami and Xiaomi
  • WeiMai
  • Jianhai Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Digital Therapeutics Platforms Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chronic Disease Digital Therapeutics
  5. 1.2.3 Psychiatric Disorders Digital Therapeutics
  6. 1.2.4 Quit Smoking Digital Therapeutics
  7. 1.2.5 Sleep Disorders and Respiratory Diseases Digital Therapeutics
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Digital Therapeutics Platforms Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Enterprise
  12. 1.3.3 Personal
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Digital Therapeutics Platforms Growth Trends by Region
  15. 1.5.1 Global Digital Therapeutics Platforms Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Digital Therapeutics Platforms Market Size by Region (2021-2026)
  17. 1.5.3 Digital Therapeutics Platforms Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Digital Therapeutics Platforms Market Dynamics
  1. 2.1 Digital Therapeutics Platforms Industry Trends
  2. 2.2 Digital Therapeutics Platforms Industry Drivers
  3. 2.3 Digital Therapeutics Platforms Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics Platforms Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Digital Therapeutics Platforms Revenue by Company (2021-2026)
  2. 3.2 Global Digital Therapeutics Platforms Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Digital Therapeutics Platforms Key Company Head office and Area Served
  4. 3.4 Global Digital Therapeutics Platforms Company, Product Type & Application
  5. 3.5 Global Digital Therapeutics Platforms Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Digital Therapeutics Platforms Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Digital Therapeutics Platforms Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Digital Therapeutics Platforms Tier 1, Tier 2, and Tier 3
4 Digital Therapeutics Platforms Market by Type
  1. 4.1 Global Digital Therapeutics Platforms Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Digital Therapeutics Platforms Market Size by Type (2021-2032)
  3. 4.3 Global Digital Therapeutics Platforms Market Size Share by Type (2021-2032)
5 Digital Therapeutics Platforms Market by Application
  1. 5.1 Global Digital Therapeutics Platforms Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Therapeutics Platforms Market Size by Application (2021-2032)
  3. 5.3 Global Digital Therapeutics Platforms Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Akili Interactive
  2. 6.1.1 Akili Interactive Company Information
  3. 6.1.2 Akili Interactive Business Overview
  4. 6.1.3 Akili Interactive Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Akili Interactive Digital Therapeutics Platforms Product Portfolio
  6. 6.1.5 Akili Interactive Recent Developments
  7. 6.2 DarioHealth
  8. 6.2.1 DarioHealth Company Information
  9. 6.2.2 DarioHealth Business Overview
  10. 6.2.3 DarioHealth Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 DarioHealth Digital Therapeutics Platforms Product Portfolio
  12. 6.2.5 DarioHealth Recent Developments
  13. 6.3 Teladoc Health
  14. 6.3.1 Teladoc Health Company Information
  15. 6.3.2 Teladoc Health Business Overview
  16. 6.3.3 Teladoc Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Teladoc Health Digital Therapeutics Platforms Product Portfolio
  18. 6.3.5 Teladoc Health Recent Developments
  19. 6.4 Voluntis
  20. 6.4.1 Voluntis Company Information
  21. 6.4.2 Voluntis Business Overview
  22. 6.4.3 Voluntis Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Voluntis Digital Therapeutics Platforms Product Portfolio
  24. 6.4.5 Voluntis Recent Developments
  25. 6.5 Sidekick Health
  26. 6.5.1 Sidekick Health Company Information
  27. 6.5.2 Sidekick Health Business Overview
  28. 6.5.3 Sidekick Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sidekick Health Digital Therapeutics Platforms Product Portfolio
  30. 6.5.5 Sidekick Health Recent Developments
  31. 6.6 WellDoc
  32. 6.6.1 WellDoc Company Information
  33. 6.6.2 WellDoc Business Overview
  34. 6.6.3 WellDoc Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 WellDoc Digital Therapeutics Platforms Product Portfolio
  36. 6.6.5 WellDoc Recent Developments
  37. 6.7 Talkspace
  38. 6.7.1 Talkspace Company Information
  39. 6.7.2 Talkspace Business Overview
  40. 6.7.3 Talkspace Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Talkspace Digital Therapeutics Platforms Product Portfolio
  42. 6.7.5 Talkspace Recent Developments
  43. 6.8 CogniFit
  44. 6.8.1 CogniFit Company Information
  45. 6.8.2 CogniFit Business Overview
  46. 6.8.3 CogniFit Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 CogniFit Digital Therapeutics Platforms Product Portfolio
  48. 6.8.5 CogniFit Recent Developments
  49. 6.9 Tata Elxsi
  50. 6.9.1 Tata Elxsi Company Information
  51. 6.9.2 Tata Elxsi Business Overview
  52. 6.9.3 Tata Elxsi Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Tata Elxsi Digital Therapeutics Platforms Product Portfolio
  54. 6.9.5 Tata Elxsi Recent Developments
  55. 6.10 Mahalo Health
  56. 6.10.1 Mahalo Health Company Information
  57. 6.10.2 Mahalo Health Business Overview
  58. 6.10.3 Mahalo Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Mahalo Health Digital Therapeutics Platforms Product Portfolio
  60. 6.10.5 Mahalo Health Recent Developments
  61. 6.11 2Morrow
  62. 6.11.1 2Morrow Company Information
  63. 6.11.2 2Morrow Business Overview
  64. 6.11.3 2Morrow Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 2Morrow Digital Therapeutics Platforms Product Portfolio
  66. 6.11.5 2Morrow Recent Developments
  67. 6.12 Omada Health
  68. 6.12.1 Omada Health Company Information
  69. 6.12.2 Omada Health Business Overview
  70. 6.12.3 Omada Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Omada Health Digital Therapeutics Platforms Product Portfolio
  72. 6.12.5 Omada Health Recent Developments
  73. 6.13 Click Therapeutics
  74. 6.13.1 Click Therapeutics Company Information
  75. 6.13.2 Click Therapeutics Business Overview
  76. 6.13.3 Click Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Click Therapeutics Digital Therapeutics Platforms Product Portfolio
  78. 6.13.5 Click Therapeutics Recent Developments
  79. 6.14 Orexo
  80. 6.14.1 Orexo Company Information
  81. 6.14.2 Orexo Business Overview
  82. 6.14.3 Orexo Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Orexo Digital Therapeutics Platforms Product Portfolio
  84. 6.14.5 Orexo Recent Developments
  85. 6.15 ResMed
  86. 6.15.1 ResMed Company Information
  87. 6.15.2 ResMed Business Overview
  88. 6.15.3 ResMed Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 ResMed Digital Therapeutics Platforms Product Portfolio
  90. 6.15.5 ResMed Recent Developments
  91. 6.16 Virta Health
  92. 6.16.1 Virta Health Company Information
  93. 6.16.2 Virta Health Business Overview
  94. 6.16.3 Virta Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Virta Health Digital Therapeutics Platforms Product Portfolio
  96. 6.16.5 Virta Health Recent Developments
  97. 6.17 Bifourmis
  98. 6.17.1 Bifourmis Company Information
  99. 6.17.2 Bifourmis Business Overview
  100. 6.17.3 Bifourmis Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Bifourmis Digital Therapeutics Platforms Product Portfolio
  102. 6.17.5 Bifourmis Recent Developments
  103. 6.18 SilverCloud (Amwell)
  104. 6.18.1 SilverCloud (Amwell) Company Information
  105. 6.18.2 SilverCloud (Amwell) Business Overview
  106. 6.18.3 SilverCloud (Amwell) Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio
  108. 6.18.5 SilverCloud (Amwell) Recent Developments
  109. 6.19 Noom
  110. 6.19.1 Noom Company Information
  111. 6.19.2 Noom Business Overview
  112. 6.19.3 Noom Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Noom Digital Therapeutics Platforms Product Portfolio
  114. 6.19.5 Noom Recent Developments
  115. 6.20 Big Health
  116. 6.20.1 Big Health Company Information
  117. 6.20.2 Big Health Business Overview
  118. 6.20.3 Big Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Big Health Digital Therapeutics Platforms Product Portfolio
  120. 6.20.5 Big Health Recent Developments
  121. 6.21 Kaia Health
  122. 6.21.1 Kaia Health Company Information
  123. 6.21.2 Kaia Health Business Overview
  124. 6.21.3 Kaia Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Kaia Health Digital Therapeutics Platforms Product Portfolio
  126. 6.21.5 Kaia Health Recent Developments
  127. 6.22 Cognoa
  128. 6.22.1 Cognoa Company Information
  129. 6.22.2 Cognoa Business Overview
  130. 6.22.3 Cognoa Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Cognoa Digital Therapeutics Platforms Product Portfolio
  132. 6.22.5 Cognoa Recent Developments
  133. 6.23 Headspace Health
  134. 6.23.1 Headspace Health Company Information
  135. 6.23.2 Headspace Health Business Overview
  136. 6.23.3 Headspace Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Headspace Health Digital Therapeutics Platforms Product Portfolio
  138. 6.23.5 Headspace Health Recent Developments
  139. 6.24 CureApp
  140. 6.24.1 CureApp Company Information
  141. 6.24.2 CureApp Business Overview
  142. 6.24.3 CureApp Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 CureApp Digital Therapeutics Platforms Product Portfolio
  144. 6.24.5 CureApp Recent Developments
  145. 6.25 Calm Health
  146. 6.25.1 Calm Health Company Information
  147. 6.25.2 Calm Health Business Overview
  148. 6.25.3 Calm Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Calm Health Digital Therapeutics Platforms Product Portfolio
  150. 6.25.5 Calm Health Recent Developments
  151. 6.26 Riva Health
  152. 6.26.1 Riva Health Company Information
  153. 6.26.2 Riva Health Business Overview
  154. 6.26.3 Riva Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Riva Health Digital Therapeutics Platforms Product Portfolio
  156. 6.26.5 Riva Health Recent Developments
  157. 6.27 Sweetch-Health
  158. 6.27.1 Sweetch-Health Company Information
  159. 6.27.2 Sweetch-Health Business Overview
  160. 6.27.3 Sweetch-Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Sweetch-Health Digital Therapeutics Platforms Product Portfolio
  162. 6.27.5 Sweetch-Health Recent Developments
  163. 6.28 Lark Health
  164. 6.28.1 Lark Health Company Information
  165. 6.28.2 Lark Health Business Overview
  166. 6.28.3 Lark Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Lark Health Digital Therapeutics Platforms Product Portfolio
  168. 6.28.5 Lark Health Recent Developments
  169. 6.29 Vida Health
  170. 6.29.1 Vida Health Company Information
  171. 6.29.2 Vida Health Business Overview
  172. 6.29.3 Vida Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 Vida Health Digital Therapeutics Platforms Product Portfolio
  174. 6.29.5 Vida Health Recent Developments
  175. 6.30 Mahana Therapeutics
  176. 6.30.1 Mahana Therapeutics Company Information
  177. 6.30.2 Mahana Therapeutics Business Overview
  178. 6.30.3 Mahana Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  179. 6.30.4 Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio
  180. 6.30.5 Mahana Therapeutics Recent Developments
  181. 6.31 Blue Note Therapeutics
  182. 6.31.1 Blue Note Therapeutics Company Information
  183. 6.31.2 Blue Note Therapeutics Business Overview
  184. 6.31.3 Blue Note Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  185. 6.31.4 Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio
  186. 6.31.5 Blue Note Therapeutics Recent Developments
  187. 6.32 Lyra Health
  188. 6.32.1 Lyra Health Company Information
  189. 6.32.2 Lyra Health Business Overview
  190. 6.32.3 Lyra Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  191. 6.32.4 Lyra Health Digital Therapeutics Platforms Product Portfolio
  192. 6.32.5 Lyra Health Recent Developments
  193. 6.33 Modern Health
  194. 6.33.1 Modern Health Company Information
  195. 6.33.2 Modern Health Business Overview
  196. 6.33.3 Modern Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  197. 6.33.4 Modern Health Digital Therapeutics Platforms Product Portfolio
  198. 6.33.5 Modern Health Recent Developments
  199. 6.34 Canary Health
  200. 6.34.1 Canary Health Company Information
  201. 6.34.2 Canary Health Business Overview
  202. 6.34.3 Canary Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  203. 6.34.4 Canary Health Digital Therapeutics Platforms Product Portfolio
  204. 6.34.5 Canary Health Recent Developments
  205. 6.35 Virgin Pulse
  206. 6.35.1 Virgin Pulse Company Information
  207. 6.35.2 Virgin Pulse Business Overview
  208. 6.35.3 Virgin Pulse Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  209. 6.35.4 Virgin Pulse Digital Therapeutics Platforms Product Portfolio
  210. 6.35.5 Virgin Pulse Recent Developments
  211. 6.36 Slanhealth
  212. 6.36.1 Slanhealth Company Information
  213. 6.36.2 Slanhealth Business Overview
  214. 6.36.3 Slanhealth Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  215. 6.36.4 Slanhealth Digital Therapeutics Platforms Product Portfolio
  216. 6.36.5 Slanhealth Recent Developments
  217. 6.37 Best Covered
  218. 6.37.1 Best Covered Company Information
  219. 6.37.2 Best Covered Business Overview
  220. 6.37.3 Best Covered Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  221. 6.37.4 Best Covered Digital Therapeutics Platforms Product Portfolio
  222. 6.37.5 Best Covered Recent Developments
  223. 6.38 Dami and Xiaomi
  224. 6.38.1 Dami and Xiaomi Company Information
  225. 6.38.2 Dami and Xiaomi Business Overview
  226. 6.38.3 Dami and Xiaomi Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  227. 6.38.4 Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio
  228. 6.38.5 Dami and Xiaomi Recent Developments
  229. 6.39 WeiMai
  230. 6.39.1 WeiMai Company Information
  231. 6.39.2 WeiMai Business Overview
  232. 6.39.3 WeiMai Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  233. 6.39.4 WeiMai Digital Therapeutics Platforms Product Portfolio
  234. 6.39.5 WeiMai Recent Developments
  235. 6.40 Jianhai Tech
  236. 6.40.1 Jianhai Tech Company Information
  237. 6.40.2 Jianhai Tech Business Overview
  238. 6.40.3 Jianhai Tech Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026)
  239. 6.40.4 Jianhai Tech Digital Therapeutics Platforms Product Portfolio
  240. 6.40.5 Jianhai Tech Recent Developments
7 North America
  1. 7.1 North America Digital Therapeutics Platforms Market Size (2021-2032)
  2. 7.2 North America Digital Therapeutics Platforms Market Size by Type
  3. 7.2.1 North America Digital Therapeutics Platforms Market Size by Type (2021-2026)
  4. 7.2.2 North America Digital Therapeutics Platforms Market Size by Type (2027-2032)
  5. 7.2.3 North America Digital Therapeutics Platforms Market Share by Type (2021-2032)
  6. 7.3 North America Digital Therapeutics Platforms Market Size by Application
  7. 7.3.1 North America Digital Therapeutics Platforms Market Size by Application (2021-2026)
  8. 7.3.2 North America Digital Therapeutics Platforms Market Size by Application (2027-2032)
  9. 7.3.3 North America Digital Therapeutics Platforms Market Share by Application (2021-2032)
  10. 7.4 North America Digital Therapeutics Platforms Market Size by Country
  11. 7.4.1 North America Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Digital Therapeutics Platforms Market Size by Country (2021-2026)
  13. 7.4.3 North America Digital Therapeutics Platforms Market Size by Country (2027-2032)
  14. 7.4.4 North America Digital Therapeutics Platforms Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Digital Therapeutics Platforms Market Size (2021-2032)
  2. 8.2 Europe Digital Therapeutics Platforms Market Size by Type
  3. 8.2.1 Europe Digital Therapeutics Platforms Market Size by Type (2021-2026)
  4. 8.2.2 Europe Digital Therapeutics Platforms Market Size by Type (2027-2032)
  5. 8.2.3 Europe Digital Therapeutics Platforms Market Share by Type (2021-2032)
  6. 8.3 Europe Digital Therapeutics Platforms Market Size by Application
  7. 8.3.1 Europe Digital Therapeutics Platforms Market Size by Application (2021-2026)
  8. 8.3.2 Europe Digital Therapeutics Platforms Market Size by Application (2027-2032)
  9. 8.3.3 Europe Digital Therapeutics Platforms Market Share by Application (2021-2032)
  10. 8.4 Europe Digital Therapeutics Platforms Market Size by Country
  11. 8.4.1 Europe Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Digital Therapeutics Platforms Market Size by Country (2021-2026)
  13. 8.4.3 Europe Digital Therapeutics Platforms Market Size by Country (2027-2032)
  14. 8.4.4 Europe Digital Therapeutics Platforms Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Digital Therapeutics Platforms Market Size (2021-2032)
  2. 9.2 China Digital Therapeutics Platforms Market Size by Type
  3. 9.2.1 China Digital Therapeutics Platforms Market Size by Type (2021-2026)
  4. 9.2.2 China Digital Therapeutics Platforms Market Size by Type (2027-2032)
  5. 9.2.3 China Digital Therapeutics Platforms Market Share by Type (2021-2032)
  6. 9.3 China Digital Therapeutics Platforms Market Size by Application
  7. 9.3.1 China Digital Therapeutics Platforms Market Size by Application (2021-2026)
  8. 9.3.2 China Digital Therapeutics Platforms Market Size by Application (2027-2032)
  9. 9.3.3 China Digital Therapeutics Platforms Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Digital Therapeutics Platforms Market Size (2021-2032)
  2. 10.2 Asia Digital Therapeutics Platforms Market Size by Type
  3. 10.2.1 Asia Digital Therapeutics Platforms Market Size by Type (2021-2026)
  4. 10.2.2 Asia Digital Therapeutics Platforms Market Size by Type (2027-2032)
  5. 10.2.3 Asia Digital Therapeutics Platforms Market Share by Type (2021-2032)
  6. 10.3 Asia Digital Therapeutics Platforms Market Size by Application
  7. 10.3.1 Asia Digital Therapeutics Platforms Market Size by Application (2021-2026)
  8. 10.3.2 Asia Digital Therapeutics Platforms Market Size by Application (2027-2032)
  9. 10.3.3 Asia Digital Therapeutics Platforms Market Share by Application (2021-2032)
  10. 10.4 Asia Digital Therapeutics Platforms Market Size by Country
  11. 10.4.1 Asia Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Digital Therapeutics Platforms Market Size by Country (2021-2026)
  13. 10.4.3 Asia Digital Therapeutics Platforms Market Size by Country (2027-2032)
  14. 10.4.4 Asia Digital Therapeutics Platforms Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Digital Therapeutics Platforms Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Digital Therapeutics Platforms Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Digital Therapeutics Platforms Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Digital Therapeutics Platforms Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst